Detection and regulation of cationic amino acid transporters in healthy and diseased ocular surface

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 3, 2009, Pages 1112-1121

  Jäger, Kristin ^a   Bönisch, Ulrike ^a   Risch, Michaela ^a   Worlitzsch, Dieter ^a   Paulsen, Friedrich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CAT 3 TRANSPORTER, HUMAN; CAT-3 TRANSPORTER, HUMAN; CYTOKINE; SLC7A1 PROTEIN, HUMAN; SLC7A2 PROTEIN, HUMAN;

ACINAR CELL; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA CELL; CORNEA DISEASE; CORNEA EPITHELIUM; EYE DISEASE; FEMALE; GENE EXPRESSION; GOBLET CELL; HERPES SIMPLEX KERATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOCONUS; LACRIMAL DUCT; LACRIMAL GLAND; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; CELL LINE; CORNEA; DRUG EFFECT; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; LACRIMAL APPARATUS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; AMINO ACID TRANSPORT SYSTEMS, BASIC; BLOTTING, WESTERN; CATIONIC AMINO ACID TRANSPORTER 1; CELL LINE; CONJUNCTIVA; CORNEA; CORNEAL DISEASES; CYTOKINES; EPITHELIUM, CORNEAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; LACRIMAL APPARATUS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAPHYLOCOCCUS AUREUS;

EID: 62649129250     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2368     Document Type: Article

References (73)

1. Hoffmann G, Schobersberger W, Rieder J, et al. Human dermal microvascrular endothelial cells express inducible nitric oxide synthase in vitro. J Invest Dermatol. 1999;112:387-390.
2. Liew FY, Cox FE. Nonspecific defence mechanism: the role of nitric oxide. Immunol Today. 1991;12:A17-A21.
3. Hazlett LD, McClellan S, Goshgarian C, Huang X, Thakur A, Barett R. The role of nitric oxide in resistance to P. aeruginosa ocular infection. Ocul Immunol Inflamm. 2005;13:279-288.
4. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell functions of pulmonary dendritic cells in vivo by resident peritoneal macrophages. J Exp Med. 1993;177:397-407.
5. Beauregard C, Brandt PC, Chiou GCY. Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1β in cultured lacrimal gland acinar cells. Exp Eye Res. 2003;77:109-114.
6. Cejkova J, Ardan T, Simonova Z, et al. Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren's syndrome). Nitric Oxide. 2007;17:10-17.
7. Bruch-Gerharz D, Schnorr O, Suschek C, et al. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol. 2003;162:203-211.
8. Horowitz S, Binion DG, Neison VM, et al. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2007;292: G1323-G1336.
9. Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev. 1998;78: 487-545.
10. Closs EI, Boissel J-P, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol. 2006;213:67-77.
11. Vekony N, Wolf S, Boissel JP, Gnauert K, Closs EI. Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry. 2001;40:12387-12394.
12. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflügers Arch. 2004;447:532-542.
13. Kawahara K, Gotoh T, Oyadomari S, et al. Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells. Brain Res Mol Brain Res. 2001;90:165-173.
14. Recker K, Klapperstück T, Kehlen A, Wohlrab J. The importance of cationic amino acid trasporter expression in human skin. J Invest Dermatol. 2003;121:1552-1553.
15. Closs EI, Lyons CR, Kelly C, Cunningham JM. Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem. 1993;268: 20796-20800.
16. Varoga D, Pufe T, Harder J, et al. Production of endogenous antibiotics in articular cartilage. Arthritis Rheum. 2004;50:3526-3534.
17. Varoga D, Pufe T, Harder J, et al. Human beta-defensin-3 mediates tissue remodelling processes in articular cartilage by increasing metalloproteinases and reducing their endogenous inhibitors TIMP-1 and 2. Arthritis Rheum. 2005;51:1736-1745.
18. Varoga D, Paulsen F, Kohrs S, et al. Expression and regulation of human beta-defensin-2 in osteoarthritic cartilage. J Pathol. 2006; 209:166-173.
19. Paulsen F, Jäger K, Worlitzsch D, Schulze U, Schäfer G, Sel S. Regulation of MUC16 by inflammatory mediators in ocular surface epithelia. Ann Anat. 2008;190:59-70.
20. + channel and NFκB activity in corneal epithelial cells. Exp Cell Res. 2005;311:39-48.
21. Habermeier A, Wolf S, Marine U, Graf P, Closs EI. Two amino acid residues determine the low substrate affinity of human cationic amino acid trasporter-2A. J Biol Chem. 2003;278:19492-19499.
22. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
23. Jäger K, Paulsen F, Wohlrab J. Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. Histochem Cell Biol. 2008;129:321-329.
24. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol. 1997;42: 71-82.
25. Schneemann A, Dijkstra BG, van den Berg TJ, Kamphuis W, Hoyng PF. Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion. Graefes Arch Clin Exp Ophthalmol. 2002;240: 936-941.
26. Rosenbaum JT, MacDevitt HO, Guess RB, Egbert PR. Endotoxin induced uveitis in rats as a model for human disease. Nature (Lond). 1980;286:611-613.
27. Parks DJ, Cheung MK, Chan CC, Roberge FG. The role of nitric oxide in uveitis. Arch Ophthalmol. 1994;112:544-546.
28. Tilton RG, Chang K, Corbett JA, et al. Endotoxin induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 1994;35:3278-3288.
29. Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y. The role of nitric oxide synthase in endotoxin-induced uveitis: effect of NG-nitro L-arginine. Invest Ophthalmol Vis Sci. 1994;35:3673-3680.
30. Meijer F, Ruijter JM, Van Delft JL, Van Haeringer NJ. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva. Eur J Pharmacol. 1995;284:61-67.
31. Meijer F, Van Delft JL, Garrelds IM, Van Haeringer NJ, Kijlstra A. Nitric oxide plays a role as a mediator of conjunctival edema in experimental allergic conjunctivitis. Exp Eye Res. 1996;62:359-365.
32. Yanagiya N, Akiba J, Kado M, Yoshida A, Kono T, Iwamoto J. Transient corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide. 1997;1:397-403.
33. Brittenden J, Heys SD, Eremin O. Immunological properties of L-arginine. In: Eremine O, ed. L-Arginine: Biological Aspects and Clinical Application. New York: Springer Verlag; 1997:79-113.
34. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N. The harmony of the spheres, inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 1996;39:875-890.
35. Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide, cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide. 1997;1:107-120.
36. Mistry SK, Zheng M, Rouse BT, Morris SM. Induction of arginases I and II in cornea during herpes simplex virus infection. Virus Res. 2001;73:177-182.
37. Cejkova J, Ardan T, Cejka C, Kovaceva J, Zidek Z. Irradiation of the rabbit cornea with UVB rays stimulates the expression of nitric oxide synthases-generated nitric oxide and the formation of cytotoxic nitrogen-related oxidants. Histol Histolpathol. 2005;20:467-473.
38. Zoukhri D, Macari E, Choi SH, Kublin CL. C-Jun HN2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion. J Neurochem. 2006;96:126-135.
39. Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2006;47:4910-4916.
40. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med. 2004;170: 148-153.
41. Schnorr O, Schuier M, Kagemann G, et al. Arginase-1 overexpression induces cationic amino acid trasporter-1 in psoriasis. Free Radic Biol Med. 2005;38:1073-1079.
42. Wittmann F, Prix N, Mayr S, et al. L-arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis. J Trauma. 2005;59:162-168.
43. MacLeod CL. Regulation of cationic amino acid transporter (CAT) gene expression. Biochem Soc Trans. 1996;24:846-852.
44. Closs EI, Scheld J-S, Sharafi M, Förstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol. 2000;57:68-74.
45. Maguire LJ, Meyer RF. Ectatic corneal degenerations. In: Kaufman HE, Barron VA, Mcdonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone; 1989:485-510.
46. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341-351.
47. Miller CA, Krachmer JH. Endothelial dystrophies. In: Kaufman HE, Barron BA, Mcdonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone; 1989:425-440.
48. Rosenthal WN, Blitzer M, Insler MS. Aqueous amino acid levels in Fuchs' corneal dystrophy. Am J Ophthalmol. 1986;102:570-574.
49. Kaufman HE, Rayfield MA. Viral conjunctivitis and keratitis. In: Kaufman HE, Barron BA, Mcdonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone; 1989:299-331.
50. Schwartz D, Schwartz IF, Gnessin E, et al. Differential regulation of glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide-treated rats. Am J Physiol Renal Physiol. 2003;284:F788-F795.
51. Rothenberg ME, Doepker MP, Lewkowich IP, et al. Cationic amino acid transporter2 regulates inflammatory homeostasis in the lung. Proc Natl Acad Sci U S A. 2006;103:14895-14900.
52. Daheshia M, Kanangat S, Rouse BT. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res. 1998;67:619-624.
53. Thomas J, Kanangat, Rouse BT. Herpes simplex virus replicationinduced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res. 1998;18:681-690.
54. Stevens BR, Vo CB. Membrane transport of neuronal nitric oxide synthase substrate L-arginine is constitutively expressed with CAT1 and 4F2hc, but not CAT2 or rBAT. J Neurochem. 1998;7: 1564-1570.
55. Gill DJ, Low BC, Grigor MR. Interleukin-1 beta and tumor necrosis factor-alpha stimulate the CAT-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells. J Biol Chem. 1996;271: 11280-11283.
56. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes: regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem. 1996;271:11694-11702.
57. Lin WC, Tsai PS, Huang CJ. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth Analg. 2005;101:226-232.
58. Yang JH, Pan CS, Jia YX, et al. Intermedin 1-53 activates Larginine/ nitric oxide synthase/nitric oxide pathway in rat aortas. Biochem Biophys Res Commun. 2006;341:567-572.
59. Fleisig SMJ, Efron N, Pier GB. Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium. Invest Ophthalmol Vis Sci. 1992;33:2908-2916.
60. O'Callaghan RJ, Cellegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571-1578.
61. Baum J. Infections of the eye. Clin Infect Dis. 1995;21:479-488.
62. Li Y, Kumar A, Gui JF, Yu FS. Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2. Microb Pathog. 2008;44:426-434.
63. Tabary O, Escotte S, Couetil J, et al. Relationship between IκBα deficiency, NFκB activity and interleukin-8 production in CF human airway epithelial cells. Pflügers Arch Eur J Physiol. 2001;443: 40-44.
64. Cheshire JL, Baldwin AS. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ. Mol Cell Biol. 1997;17:6746-6754.
65. Dragneva Y, Anuradha CD, Valeva A, Hoffmann A, Bhakdi S, Husman M. Subcyticidal attack by staphylococcal alpha-toxin activates NF-κB and induces interleukin-8 production. Infect Immun. 2001; 69:2630-2635.
66. Hammermann R, Dreissig MD, Mössner J, et al. Nuclear factor-κB mediates simultaneous induction of inducible nitric-oxide synthase and up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages. Mol Pharmacol. 2000;58:1294-1302.
67. Visigalli R, Bussolati O, Sala R, et al. The stimulation of arginine transport by TNF-α in human endothelial cells depends on NF-κB activation. Biochim Biophys Acta. 2004;1664:45-52.
68. Galimand M, Camper M, Zimmermann A, Haas D. Positive FNR-like control of anaerobic arginine degradation and nitrate respiration in Pseudomonas aeruginosa. J Bacteriol. 1991;173:1598-1606.
69. Veroogt HJ, Smit H, Abee T, et al. arcD, the first gene of the arc poeron for anaerobic arginine catabolism in Pseudomonas aeruginosa, encodes an arginine-ornithine exchanger. J Bacteriol. 1992; 174:1568-1573.
70. Sala R, Rotoli BM, Colla E, et al. Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+). Am J Physiol Cell Physiol. 2002;282:C134-C143.
71. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf. 2004;2:229-247.
72. Zou G, de Leeuw E, Li C, et al. Toward understanding the cationicity of defensins: Arg and Lys versus their noncoded analogs. J Biol Chem. 2007;282:19653-19665.
73. Thompson RW, Pesce JT, Tamalingam T, et al. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLOS Pathog. 2008;4:e1000023.